Drawing for BIONYC

USPTO serial 86555470

BIONYC

Reviewed by CopyMark Law Group

Reg. 5205356Status 702Renewal
Filing date
Status date
Registration date
May 16, 2017
Examiner
STRINGER, DANIEL
Law office
TMEG LAW OFFICE 103

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 702: Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use.

Need help with BIONYC?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $399*

Plus Government fees of $650

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Lori P. Hager, Esq.

Lori P. Hager, Esq. KYBERIA LEGAL, LLCSuite 50150 Division St.Somerville, NJ 08876

Goods and services

ClassDescriptionStatusFirst use
035Advertising agencies specializing in pharmaceutical branding, product launch and consulting; Advertising and marketing consultancy; Advertising and publicity services, namely, promoting the goods, services, brand identity and commercial information and news of third parties through digital technology, video, and live events; Advertising consultation; Advertising services in the field of pharmaceuticals; Advertising services, namely, creating corporate and brand identity for others; Advertising services, namely, promoting and marketing the goods and services of others in the field of pharmaceuticals via print and electronic media; Advertising, marketing and promotion services in the field of pharmaceuticals; Brand concept and brand development services for corporate clients; Business consultation in the field of pharmaceuticals; Concept and brand development in the pharmaceuticals; Concept and brand development services for corporate clients; Conducting market surveys; Digital advertising services; Market analysis and research services; Marketing consultation in the field of pharmaceuticals; Marketing consulting; Marketing plan development; Providing advertising, marketing and promotional services for the pharmaceutical and medical industry; Providing advertising, marketing and promotional services for the pharmaceutical and medical products of othersACTIVEDec 2, 2014

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 16, 2026REM2COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED—
May 4, 2024NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
May 4, 2024C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
May 4, 2024APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Nov 6, 2023E815TEAS SECTION 8 & 15 RECEIVED—
May 16, 2022REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Sep 1, 2021ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
Jul 3, 2019ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
Jul 19, 2017ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
May 16, 2017R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Apr 15, 2017SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Apr 13, 2017CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Mar 30, 2017SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Mar 26, 2017AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Mar 15, 2017IUAFUSE AMENDMENT FILED—
Mar 15, 2017EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Nov 19, 2016EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Nov 17, 2016EX1GSOU EXTENSION 1 GRANTED—
Nov 17, 2016EXT1SOU EXTENSION 1 FILED—
Nov 17, 2016EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 17, 2016NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Mar 22, 2016NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 22, 2016PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 2, 2016NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 17, 2016PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Feb 16, 2016CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 16, 2016TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Feb 16, 2016CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 10, 2016ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Jan 5, 2016RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Jan 5, 2016ALIEASSIGNED TO LIE—
Jun 16, 2015GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Jun 16, 2015GNSLLETTER OF SUSPENSION E-MAILED—
Jun 16, 2015CNSLSUSPENSION LETTER WRITTEN—
Jun 11, 2015DOCKASSIGNED TO EXAMINER—
Mar 20, 2015MPMKNOTICE OF PSEUDO MARK E-MAILED—
Mar 19, 2015NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 10, 2015NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance